|
|
Volumn 11, Issue 6, 2006, Pages 178-
|
|
Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
ESTROGEN RECEPTOR;
PLACEBO;
RALOXIFENE;
ACUTE CORONARY SYNDROME;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
DEATH;
ENDOMETRIUM CANCER;
FEMALE;
GALLBLADDER DISEASE;
HEART INFARCTION;
HIGH RISK POPULATION;
HOSPITAL ADMISSION;
HOT FLUSH;
HUMAN;
ISCHEMIC HEART DISEASE;
LEG CRAMP;
PERIPHERAL EDEMA;
POSTMENOPAUSE;
PRIMARY PREVENTION;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SHORT SURVEY;
STROKE;
VENOUS THROMBOEMBOLISM;
VERTEBRA FRACTURE;
|
|
EID: 33845745279
PISSN: 13565524
EISSN: None
Source Type: Journal
DOI: 10.1136/ebm.11.6.178 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (3)
|
